LOUISVILLE, Ky. – Digital health platform provider Revon Systems Inc. will support ClinTec International, a contract research organization, as the symptom tracking technology provider for a year-long real world natural history study in the United Kingdom for patients diagnosed with a rare blood disease.
“This rare disease study is the perfect project for REVON because of their need for both patient and physician secure data capture on the smartphone or during the office visit,” said Dr. Ted Smith, CEO of Revon Systems, in a statement.
The Revon Systems platform will securely collect patient symptom surveys and patient activity data. Patients will report their symptoms using REVON’s software from their smartphones and integrated Misfit activity trackers. The platform also offers robust support for physician-reported outcomes from office visits.
“Our goal is to help our biotech clients meet their research needs and Revon Systems adds that real world data dimension to this natural history study with their ability to handle patient and physician reported clinical outcomes with Bluetooth connected devices,” said Dr. Rabinder Buttar, founder and CEO of ClinTec, in a statement.